Page last updated: 2024-10-31
methyl methanesulfonate and Leukemia
methyl methanesulfonate has been researched along with Leukemia in 1 studies
Leukemia: A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006)
Research Excerpts
Excerpt | Relevance | Reference |
---|---|---|
"The effective dose (ED) is the pharmaceutical dosage required to produce a therapeutic response in a fixed proportion of the patients." | 1.40 | A random set approach to confidence regions with applications to the effective dose with combinations of agents. ( Jankowski, H; Ji, X; Stanberry, L, 2014) |
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Jankowski, H | 1 |
Ji, X | 1 |
Stanberry, L | 1 |
Other Studies
1 other study available for methyl methanesulfonate and Leukemia
Article | Year |
---|---|
A random set approach to confidence regions with applications to the effective dose with combinations of agents.
Topics: Algorithms; Animals; Computer Simulation; Confidence Intervals; Decompression Sickness; HL-60 Cells; | 2014 |